BEAM News and Press, Beam Therapeutics Inc. From 08/09/22

Beam Therapeutics press release ( NASDAQ: BEAM ): Q2 GAAP EPS of -$1.02 misses by $0.05 . Revenue of $16.65M beats by $7.21M . Cash, cash equivalents and marketable securities were $1.2 billion as of June 30, 2022, as compared to $965.6 million as of December 3...

Patient Enrollment into BEACON Phase 1/2 Trial of BEAM-101 On-track for Second Half of 2022 BEAM-201 IND Submitted to FDA; Currently on Clinical Hold BEAM-102 IND Submission and BEAM-301 IND-enabling Studies On-track for Second Half of 2022 John Lo, Ph.D., Appoin...

Barclays is skeptical about a Goldilocks narrative for stocks where weak data and peak inflation push central banks to the dovish side. Investors should fade the recent rally, but keep in mind that sentiment is still very bearish and could extend a short squeeze, according to equity...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Gene editing stocks are the talk of Wall Street today as a number of biotech titans enjoy strong gains. It seems a breakthrough clinical trial from Alnylam Pharmaceuticals (NASDAQ: ALNY ) has lifted the entire industry. ...

Biotechnology and genomics-based exchange traded funds like the Genomics & Biotechnology ETF ( NASDAQ: GNOM ) and ARK Genomics ETF ( BATS: ARKG ) jumped higher on Wednesday’s session off the back of healthcare tech stocks. GNOM +5.7% and ARKG +5% c...

CAMBRIDGE, Mass., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer, will participate in a panel titled, “So Let it...

Beam Therapeutics (NASDAQ: BEAM) , a pre-clinical gene-editing company, saw its shares dip by as much as 9.8% in early morning trading Monday. The biotech's stock has recovered to a degree as today's session has unfolded, but its shares were still down by 3.64% as of 12:49 p.m. ET M...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Sundry Photography / Shutterstock.com Target (NYSE: TGT ) stock is in the news today as investors react to a new note from Jefferies that gives the retail company flak. Jefferies analyst Stephanie Wi...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Natali_ Mis/ShutterStock.com Beam Therapeutics (NASDAQ: BEAM ) stock is slipping on Monday after the U.S. Food and Drug Administration (FDA) placed a clinical hold on one of its drugs . According to a...

Cathie Wood’s flagship ARK Innovation ETF ( NYSEARCA: ARKK ) snapped its eight-month losing streak, finishing July with an advance for the month. This was the first positive monthly performance since October of 2021. ARKK concluded the month of July +13.6% and ama...